• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter Results

    2/12/25 4:44:00 PM ET
    $SSY
    Hospital/Nursing Management
    Health Care
    Get the next $SSY alert in real time by email

    SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $1,070,000 (or a loss of $0.15 per fully diluted share) for its second fiscal quarter ended December 31, 2024 compared to a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for the second fiscal quarter ended December 31, 2023. During the quarter ended December 31, 2024, the Company recorded an impairment loss of $100,000 to write down the value of the net assets of its information technology business which sold in January 2025.

    Net loss for the quarter ended December 31, 2024 was $1,343,000 (or a loss of $0.19 per fully diluted share) compared to a net loss of $3,075,000 (or a loss of $0.44 per fully diluted share) for the quarter ended December 31, 2023. The net loss for the second fiscal quarter of 2025 included a loss from discontinued operations of $273,000 (or a loss of $0.04 fully diluted share), which includes a loss of $110 on the sale of real estate in Houston, Mississippi. The net loss for the second fiscal quarter of 2024 included a loss from discontinued operations of $2,668,000 (or a loss of $0.38 per fully diluted share), which includes for the quarter an impairment loss of $2,032,000 on the sale of the Trace Regional Hospital, a vacant medical office building and three (3) patient clinics and a loss from operations of $636,000, primarily from operations of Trace Regional Hospital (prior to its sale) and a nursing home in Houston, Mississippi.

    Consolidated net revenues for the fiscal quarters ended December 31, 2024 and 2023 were $7,935,000 and $8,510,000, respectively, which consisted primarily of pharmacy net revenues. Pharmacy net revenues for the quarter ended December 31, 2024 decreased $575,000, or 7%, from the same period last year. The pharmacy business had lower retail pharmacy scripts and durable medical equipment orders filled this year.

    SunLink reported an operating loss for the quarter ended December 31, 2024 of $1,012,000 compared to an operating loss for the quarter ended December 31, 2023 of $433,000.

    SunLink reported a loss from continuing operations of $1,512,000 (or a loss of $0.21 per fully diluted share) for its six months ended December 31, 2024 compared to a loss from continuing operations of $835,000 (or $0.12 per fully diluted share) for the six months ended December 31, 2023. Net loss for the six months ended December 31, 2024 was $1,892,000 (or a loss of $0.27 per fully diluted share) compared to a net loss of $4,419,000 (or $0.63 per fully diluted share) for the six months ended December 31, 2023. The net loss for the six months ended December 31, 2024 included a loss from discontinued operations of $380,000 (or a loss of $0.05 per fully diluted share), compared to a loss from discontinued operations of $3,584,000 (or a loss of $0.51 per fully diluted share) for the six months ended December 31, 2023. The discontinued operations loss for the six months ended December 31, 2024 includes a loss of $110,000 on the October 2024 property sale in Houston, Mississippi. The discontinued operations loss for the six months ended December 31, 2023 included an impairment loss of $2,032,000 on the sale of the Trace Regional Hospital, a vacant medical office building and three (3) patient clinics and loss from operations of $1,552,000, primarily from Trace Regional Hospital (prior to its sale) and a nursing home in Houston, Mississippi. Consolidated net revenues for each of the six months ended December 31, 2024 and 2023 were $15,858,000 and $17,065,000, respectively. Pharmacy net revenues for the six months ended December 31, 2023 included $380,000 from the reversal of reserves for certain sales taxes previously accrued. Excluding the effect of the reversal of sales tax accruals, net revenues decreased 5% in the six months ended December 31, 2024 compared to the prior year due primarily to decreased volume of Retail pharmacy scripts filled.

    SunLink reported an operating loss for the six months ended December 31, 2024 of $2,206,000 compared to an operating loss for the six months ended December 31, 2023 of $883,000. The operating loss during the comparable six month period last year resulted primarily from the lower net revenues partially offset by the reversal of $380,000 in accrued sales tax reserves.

    Merger

    On January 6, 2025, the Company and Regional Health Properties, Inc. ("Regional") jointly announced that they have entered into a definitive agreement and plan of merger (the "merger agreement"), dated January 3, 2025 pursuant to which the Company will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of 1,410,000 shares of Regional common stock and 1,410,000 shares of Regional's newly-authorized Series D 8% Cumulative Convertible Redeemable Preferred Stock with a liquidation preference of $10 per share. The merger has been approved unanimously by each company's board of directors and completion of the transaction is subject to the receipt of the approvals of the shareholders of both Regional and the Company, regulatory approvals, and satisfaction of customary closing conditions.

    COVID-19 Pandemic

    The Company continues to experience post-COVID-19 pandemic after-effects in its quarter and believes it will likely to continue experience these effects on its assets and operations in the foreseeable future particularly from salaries and wages pressure, workforce shortages, supply chain disruption and broad inflationary pressures. Our ability to make estimates of any such continuing effects on future revenues, expenses or changes in accounting judgments that have had or are reasonably likely to have a material effect on our financial statements is very limited, depending as they do on the severity and length thereof; as well as any further government actions and/or regulatory changes intended to address such effects.

    SunLink Health Systems, Inc. is the parent company of subsidiaries that own and operate a pharmacy business and an information technology business in the Southeast (the latter of which sold on January 6, 2025). For additional information on SunLink Health Systems, Inc., please visit the Company's website.

    This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, without limitation, statements regarding the company's business strategy. These forward-looking statements are subject to certain risks, uncertainties, and other factors, which could cause actual results, performance, and achievements to differ materially from those anticipated. Certain of those risks, uncertainties and other factors are disclosed in more detail in the company's Annual Report on Form 10-K for the year ended June 30, 2024 and other filings with the Securities and Exchange Commission which can be located at www.sec.gov.

    SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES
    FISCAL 2025 SECOND QUARTER RESULTS
    Amounts in 000's, except per share
     
    CONSOLIDATED STATEMENTS OF EARNINGS (LOSS)
    Three Months Ended December 31, Six Months Ended December 31,

    2024

    2023

    2024

    2023

    % of Net % of Net % of Net % of Net
    Amount Revenues Amount Revenues Amount Revenues Amount Revenues
    Net revenues

    $

    7,935

     

     

    100.0

    %

    $

    8,510

     

    100.0

    %

    $

    15,858

     

    100.0

    %

    $

    17,065

     

    100.0

    %

    Costs and Expenses:
    Cost of goods sold

     

    4,618

     

     

    58.2

    %

     

    4,761

     

    55.9

    %

     

    9,093

     

    57.3

    %

     

    9,532

     

    55.9

    %

    Salaries, wages and benefits

     

    2,713

     

     

    34.2

    %

     

    2,668

     

    31.4

    %

     

    5,791

     

    36.5

    %

     

    5,285

     

    31.0

    %

    Supplies

     

    40

     

     

    0.5

    %

     

    39

     

    0.5

    %

     

    74

     

    0.5

    %

     

    73

     

    0.4

    %

    Purchased services

     

    326

     

     

    4.1

    %

     

    281

     

    3.3

    %

     

    645

     

    4.1

    %

     

    567

     

    3.3

    %

    Other operating expenses

     

    833

     

     

    10.5

    %

     

    784

     

    9.2

    %

     

    1,637

     

    10.3

    %

     

    1,690

     

    9.9

    %

    Rent and leases

     

    93

     

     

    1.2

    %

     

    92

     

    1.1

    %

     

    187

     

    1.2

    %

     

    183

     

    1.1

    %

    Depreciation and amortization

     

    324

     

     

    4.1

    %

     

    318

     

    3.7

    %

     

    637

     

    4.0

    %

     

    618

     

    3.6

    %

    Operating loss

     

    (1,012

    )

     

    -12.8

    %

     

    (433

    )

    -5.1

    %

     

    (2,206

    )

    -13.9

    %

     

    (883

    )

    -5.2

    %

     
    Interest Income - net

     

    42

     

     

    0.5

    %

     

    29

     

    0.3

    %

     

    100

     

    0.6

    %

     

    51

     

    0.3

    %

    Impairment loss

     

    (100

    )

     

    -1.3

    %

     

    0

     

    0.0

    %

     

    (100

    )

    -0.6

    %

     

    0

     

    0.0

    %

    Gain on sale of assets

     

    0

     

     

    0.0

    %

     

    0

     

    0.0

    %

     

    694

     

    4.4

    %

     

    2

     

    0.0

    %

     
    Loss from Continuing Operations before
    Income Taxes

     

    (1,070

    )

     

    -13.5

    %

     

    (404

    )

    -4.7

    %

     

    (1,512

    )

    -9.5

    %

     

    (830

    )

    -4.9

    %

    Income Tax expense

     

    0

     

     

    0.0

    %

     

    3

     

    0.0

    %

     

    0

     

    0.0

    %

     

    5

     

    0.0

    %

    Loss from Continuing Operations

     

    (1,070

    )

     

    -13.5

    %

     

    (407

    )

    -4.8

    %

     

    (1,512

    )

    -9.5

    %

     

    (835

    )

    -4.9

    %

    Loss from Discontinued Operations, net of tax

     

    (273

    )

     

    -3.4

    %

     

    (2,668

    )

    -31.4

    %

     

    (380

    )

    -2.4

    %

     

    (3,584

    )

    -21.0

    %

    Net Loss

    $

    (1,343

    )

     

    -16.9

    %

    $

    (3,075

    )

    -36.1

    %

    $

    (1,892

    )

    -11.9

    %

    $

    (4,419

    )

    -25.9

    %

    Loss Per Share from Continuing Operations:
    Basic

    $

    (0.15

    )

    $

    (0.06

    )

    $

    (0.21

    )

    $

    (0.12

    )

    Diluted

    $

    (0.15

    )

    $

    (0.06

    )

    $

    (0.21

    )

    $

    (0.12

    )

    Loss Per Share from Discontinued Operations:
    Basic

    $

    (0.04

    )

    $

    (0.38

    )

    $

    (0.05

    )

    $

    (0.51

    )

    Diluted

    $

    (0.04

    )

    $

    (0.38

    )

    $

    (0.05

    )

    $

    (0.51

    )

    Net Loss Per Share:
    Basic

    $

    (0.19

    )

    $

    (0.44

    )

    $

    (0.27

    )

    $

    (0.63

    )

    Diluted

    $

    (0.19

    )

    $

    (0.44

    )

    $

    (0.27

    )

    $

    (0.63

    )

    Weighted Average Common Shares Outstanding:
    Basic

     

    7,041

     

     

    7,040

     

     

    7,041

     

     

    7,039

     

    Diluted

     

    7,041

     

     

    7,040

     

     

    7,041

     

     

    7,039

     

     
     
    SUMMARY BALANCE SHEETS December 31, June 30,

     

    2024

     

     

    2024

     

    ASSETS
    Cash and Cash Equivalents

    $

    8,020

     

    $

    7,170

     

    Receivable - net

     

    2,831

     

     

    3,371

     

    Current Assets Held for Sale

     

    256

     

     

    1,959

     

    Other Current Assets

     

    3,099

     

     

    3,164

     

    Property Plant and Equipment, net

     

    2,053

     

     

    2,809

     

    Long-term Assets

     

    1,613

     

     

    2,139

     

    $

    17,872

     

    $

    20,612

     

    LIABILITIES AND SHAREHOLDERS' EQUITY
    Current Liabilities

    $

    3,495

     

    $

    4,213

     

    Noncurrent Liabilities

     

    296

     

     

    426

     

    Shareholders' Equity

     

    14,081

     

     

    15,973

     

    $

    17,872

     

    $

    20,612

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250212287098/en/

    Robert M. Thornton, Jr.

    Chief Executive Officer

    (770) 933-7004

    Get the next $SSY alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $SSY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SSY
    SEC Filings

    See more
    • SEC Form 425 filed by SunLink Health Systems Inc.

      425 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)

      7/30/25 10:35:16 AM ET
      $SSY
      Hospital/Nursing Management
      Health Care
    • SunLink Health Systems Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - SUNLINK HEALTH SYSTEMS INC (0000096793) (Filer)

      7/29/25 4:59:05 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care
    • SEC Form 425 filed by SunLink Health Systems Inc.

      425 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)

      7/25/25 9:23:24 AM ET
      $SSY
      Hospital/Nursing Management
      Health Care

    $SSY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SunLink Health Systems, Inc. Adjourns Special Meeting Until August 4, 2025 and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger With Regional Health Properties, Inc. by August 3, 2025 at 11:59 PM EDT

      SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) today announced that SunLink convened its special meeting (the "Special Meeting") of the holders of its common stock (the "Common Stock") on July 29, 2029, and the holders of the Common Stock approved the adjournment of the Special Meeting. The Special Meeting will reconvene on Monday, August 4, 2025, at 10:00 a.m., Eastern Time, at Hyatt House Hotel, 3595 Cumberland Blvd., Atlanta, Georgia 30339. The record date for determination of the holders of the Common Stock entitled to notice of, and to vote at, the reconvened Special Meeting remains the close of business on June 20, 2025. Any proxies previously submitted by the holders of the Co

      7/29/25 4:34:00 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care
    • SunLink Health Systems, Inc. provides an Update on Proxy Voting for the Proposed Merger with Regional Health Properties, Inc. and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger by July 28, 2025 at 11:59 PM EDT

      Over 99% of the SunLink shares voted to date have shown support "FOR" the merger proposal, but additional votes are needed in order to approve SunLink's proposed merger with Regional SunLink Health Systems, Inc. (NYSE:SSY) today urges its stockholders of record as of June 20, 2025 to vote in favor of all of the proposals outlined in the definitive joint proxy statement/prospectus (the "Proxy Statement") for the upcoming Special Meeting of SunLink stockholders to be held at 10:00 AM EDT on Tuesday, July 29, 2025 to approve the proposed Merger with Regional Health Properties, Inc. Robert M. Thornton, Jr., Chief Executive Officer of SunLink, commented, "We appreciate the strong support fro

      7/24/25 6:13:00 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care
    • SunLink Health Systems, Inc. Provides Update on Special Cash Dividend Scheduled to Be Paid Prior to SunLink's Proposed Merger with Regional Health Properties, Inc.

      SunLink Health Systems, Inc. (NYSE:SSY) today issued the following update with respect to its scheduled $0.10 per share special cash dividend approved by SunLink's Board of Directors and previously announced on July 18, 2025 (the "Special Cash Dividend"). SunLink understands that trades of SunLink common stock entered into during the period (the "due bill period") beginning July 29, 2025 (the record date for the Special Cash Dividend) and through July 30, 2025 (the payment date for the Special Cash Dividend) will have a due bill attached for the Special Cash Dividend. Due bills obligate sellers to deliver the Special Cash Dividend to the buyer. This means that persons who purchase SunLink

      7/24/25 1:03:00 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care

    $SSY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Turner Howard E bought $968 worth of shares (1,000 units at $0.97), increasing direct ownership by 0.49% to 205,785 units (SEC Form 4)

      4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

      11/28/23 3:17:47 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care
    • Baileys Steven J returned 832,844 units of Series C Fractional Interests to the company, closing all direct ownership in the company (SEC Form 4)

      4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

      10/23/23 3:37:35 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care
    • Turner Howard E returned 233,004 units of Series C Fractional Interests to the company, closing all direct ownership in the company (SEC Form 4)

      4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

      10/23/23 3:22:14 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care

    $SSY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Turner Howard E bought $968 worth of shares (1,000 units at $0.97), increasing direct ownership by 0.49% to 205,785 units (SEC Form 4)

      4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)

      11/28/23 3:17:47 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care

    $SSY
    Financials

    Live finance-specific insights

    See more
    • SunLink Health Systems, Inc. Provides Update on Special Cash Dividend Scheduled to Be Paid Prior to SunLink's Proposed Merger with Regional Health Properties, Inc.

      SunLink Health Systems, Inc. (NYSE:SSY) today issued the following update with respect to its scheduled $0.10 per share special cash dividend approved by SunLink's Board of Directors and previously announced on July 18, 2025 (the "Special Cash Dividend"). SunLink understands that trades of SunLink common stock entered into during the period (the "due bill period") beginning July 29, 2025 (the record date for the Special Cash Dividend) and through July 30, 2025 (the payment date for the Special Cash Dividend) will have a due bill attached for the Special Cash Dividend. Due bills obligate sellers to deliver the Special Cash Dividend to the buyer. This means that persons who purchase SunLink

      7/24/25 1:03:00 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care
    • SunLink Health Systems, Inc Declares Special Cash Dividend Prior to with the Proposed Merger with Regional Health Properties, Inc.

      SunLink Health Systems, Inc. (NYSE:SSY) today announced that its Board of Directors has declared a special cash dividend (the "Special Cash Dividend") prior to the previously announced proposed merger (the "Merger") with Regional Health Properties, Inc. ("Regional") pursuant to the Amended and Restated Agreement and Plan of Merger, dated April 14, 2025, as amended (the "Merger Agreement"). The Special Cash Dividend will be $0.10 per share, payable in cash to the stockholders of record as of July 29, 2025. The aggregate estimated payment for the Special Cash Dividend is expected to be approximately $704,600, based on 7,040,603 shares of SunLink's common stock outstanding as of June 20, 2025.

      7/21/25 9:01:00 AM ET
      $SSY
      Hospital/Nursing Management
      Health Care
    • REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTION

      Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (OTCQB:RHEP) (OTCQB:RHEPA) and SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) jointly announced today that they have entered into an amended and restated agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of approximately 1,595,401 shares of Regional common stock and 1,408,121 shares of Regional's newly-authorized Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Regional Series D Preferred Stock") with an initial liquidation preference o

      4/15/25 8:00:00 AM ET
      $SSY
      Hospital/Nursing Management
      Health Care

    $SSY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by SunLink Health Systems Inc. (Amendment)

      SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)

      11/13/23 5:26:31 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13D/A filed by SunLink Health Systems Inc. (Amendment)

      SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)

      7/24/23 5:26:50 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13D/A filed by SunLink Health Systems, Inc. (Amendment)

      SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)

      5/24/21 3:48:59 PM ET
      $SSY
      Hospital/Nursing Management
      Health Care